Hybrid Medical Analytics CIO Reports Our Sybase Geonomics Glioblastoma Data Mining Shows that the PTPRD Gene shows to be Promising.

Biotech: Hybrid Medical Analytics CIO Reports that our Sybase Geonomics Glioblastoma Data Mining Shows that the PTPRD Gene shows to be Promising.

Three of every 100,000 Americans have been diagnosed with glioblastoma multiforme ....malignant brain tumors. Most patients with glioblastoma die of the disease within approximately 14 months of diagnosis.

Glioblastoma is not a single disease that appears to be four distinct molecular subtypes Cancer Cell,Investigation of targeted Therapies may improve the near uniformly fatal prognosis of this cancer.

The ability to differentiate Glioblastoma Tumors based on their altered genetic code.Using a cancer's genome to unravel the molecular changes. Comprehensive and coordinated effort to accelerate understanding of how molecular can help extend life
based on cancer through the application of genome analysis technologies and large-scale genome sequencing.

Hybrid Medical analysis Geonomics shows the PTPRD mutations in both the blood and in tumors of a patient with Glioblastoma cancers, can be responsible for an inherited susceptibale to Brain Cancer.

Hybrid Medical Analytics Area of Research

* Breast cancer
* Endocrine system cancer
* Gastrointestinal cancer
* Genitourinary cancer
* Gynaecological cancer
* Haematological cancer
* Head and neck cancer
* Neurooncology
* Paediatric oncology
* Thoracic oncology
* Sarcoma
* Skin cancer
* Epidemiology, cancer prevention, and cancer control
* Supportive care
* Imaging
* Health-care systems